224P Neoadjuvant pyrotinib plus trastuzumab, docetaxel, and carboplatin in patients with HER2-positive early breast cancer: A single-group, multicenter, phase II study
Z. Liu
◽
J. Zhu
◽
C. Wang
◽
X. Sun
◽
Z. Lu
◽
...
Minesh Mehta
◽
Manmeet Ahluwalia
2019 ◽
Vol 26
(8)
◽
pp. 2428-2434
◽
Masataka Sawaki
◽
Takeshi Miyamoto
◽
Tomomi Fujisawa
◽
Yoshiyuki Itoh
◽
Takeshi Ebara
◽
...
2009 ◽
Vol 15
(4)
◽
pp. 1452-1459
◽
Nancy U. Lin
◽
Véronique Diéras
◽
Devchand Paul
◽
Dominique Lossignol
◽
Christos Christodoulou
◽
...
2004 ◽
Vol 130
(11)
◽
pp. 657-663
P. Schmid
◽
J. Krocker
◽
G. Morack
◽
V. Heilmann
◽
J.-U. Blohmer
◽
...
2021 ◽
Vol 152
◽
pp. 223-232
Joyce O'Shaughnessy
◽
Susana Sousa
◽
Josefina Cruz
◽
Lesley Fallowfield
◽
Päivi Auvinen
◽
...
M Martín
◽
A Makhson
◽
J Gligorov
◽
M Lichinitser
◽
A Lluch
◽
...
S. Pernas Simon
◽
M. Rezai
◽
M. Hauschild
◽
J.P. Machiels
◽
S. Paepke
◽
...
2009 ◽
Vol 2009
◽
pp. 13-14
2010 ◽
Vol 28
(15_suppl)
◽
pp. 681-681
T. Saeki
◽
K. Aogi
◽
S. Nakamura
◽
M. Kashiwaba
◽
N. Sato
◽
...
2012 ◽
Vol 23
◽
pp. ix83
◽
A. Schneeweiss
◽
S. Chia
◽
R. Hegg
◽
C. Tausch
◽
R. Deb
◽
...
Close
Export Citation Format
Close
Share Document
Close